Christoph B. Olivier
Hugstetter Str. 55
Freiburg, BW 79106, Germany
Freiburg, BW 79106, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 63 publications
Dual antithrombotic therapy using potent antiplatelet inhibitors in atrial fibrillation and acute coronary syndrome: a randomized controlled trial.
Journal: Nature medicine
Published: July 02, 2026
Injectable antiplatelet therapies in acute coronary syndromes: Current status and Emerging Therapies. A position paper of the Task Force of Antithrombotic therapy of the ACVC.
Journal: European heart journal. Acute cardiovascular care
Published: May 26, 2026
Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for Acute Pulmonary Embolism.
Journal: The New England journal of medicine
Published: March 30, 2026
CYP2C19 Polymorphism and Platelet Aggregation-Associated Risks in Atrial Fibrillation Patients Undergoing PCI.
Journal: Clinical and translational science
Published: December 21, 2025
Radial versus femoral secondary access in patients undergoing TAVI - Rationale and Design of the RADIAL-TAVI trial.
Journal: The American journal of cardiology
Published: October 07, 2025
Radial Versus Femoral Secondary Access in Patients Undergoing TAVI: Rationale and Design of the RADIAL-TAVI Trial.
Journal: The American journal of cardiology
Published: October 07, 2025
Letter to the Editor - Optimizing Culotte Technique with Double Kissing Balloon Inflation: A Response to Berkay Serter´s Letter to the Editor.
Journal: Journal of cardiovascular translational research
Published: August 01, 2025
Immunological risk identified by single-cell multi-omics and cardiovascular outcomes.
Journal: European heart journal
Published: June 01, 2025
Aspirin in Dual Antiplatelet Therapy After PCI: One Duration Does Not Fit All.
Journal: Circulation. Cardiovascular interventions
Published: May 30, 2025
Associations of biomarkers with hypoattenuated leaflet thickening after transcatheter aortic valve replacement.
Journal: Research and practice in thrombosis and haemostasis
Published: May 22, 2025
Fibrin clot strength is associated with increased risk of major adverse cardiac events after TAVR.
Journal: Clinical research in cardiology : official journal of the German Cardiac Society
Published: May 06, 2025
Last Updated: 09/26/2026